BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2040716)

  • 1. Fluoxetine treatment of bipolar II depression.
    Simpson SG; DePaulo JR
    J Clin Psychopharmacol; 1991 Feb; 11(1):52-4. PubMed ID: 2040716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mania associated with fluoxetine treatment in adolescents.
    Venkataraman S; Naylor MW; King CA
    J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):276-81. PubMed ID: 1564030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report.
    Weilburg JB; Rosenbaum JF; Biederman J; Sachs GS; Pollack MH; Kelly K
    J Clin Psychiatry; 1989 Dec; 50(12):447-9. PubMed ID: 2600061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression.
    Rothschild AJ; Samson JA; Bessette MP; Carter-Campbell JT
    J Clin Psychiatry; 1993 Sep; 54(9):338-42. PubMed ID: 8104930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium therapy for unipolar and bipolar depression among the middle-aged and older adult patient subpopulation.
    Lepkifker E; Iancu I; Horesh N; Strous RD; Kotler M
    Depress Anxiety; 2007; 24(8):571-6. PubMed ID: 17133442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Frequency of bipolar affective disorders among depressive outpatients treated by psychiatrists].
    Rybakowski J; Suwalska A; Lojko D; Rymaszewska J; Kiejna A
    Psychiatr Pol; 2004; 38(2):203-16. PubMed ID: 15307287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoxetine in depressed patients: a comparison with imipramine.
    Bremner JD
    J Clin Psychiatry; 1984 Oct; 45(10):414-9. PubMed ID: 6384203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of fluoxetine combined with a heterocyclic antidepressant in treatment-resistant depression: a retrospective analysis.
    Zajecka JM; Jeffries H; Fawcett J
    J Clin Psychiatry; 1995 Aug; 56(8):338-43. PubMed ID: 7635848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose valproate: a new treatment for cyclothymia, mild rapid cycling disorders, and premenstrual syndrome.
    Jacobsen FM
    J Clin Psychiatry; 1993 Jun; 54(6):229-34. PubMed ID: 8331092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risperidone in the treatment of affective illness and obsessive-compulsive disorder.
    Jacobsen FM
    J Clin Psychiatry; 1995 Sep; 56(9):423-9. PubMed ID: 7545159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoxetine, a selective serotonin uptake inhibitor, for the treatment of outpatients with major depression.
    Byerley WF; Reimherr FW; Wood DR; Grosser BI
    J Clin Psychopharmacol; 1988 Apr; 8(2):112-5. PubMed ID: 3286684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed depression: a clinical marker of bipolar-II disorder.
    Benazzi F
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):267-74. PubMed ID: 15694234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
    Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S
    Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Problem-solving ability and comorbid personality disorders in depressed outpatients.
    Harley R; Petersen T; Scalia M; Papakostas GI; Farabaugh A; Fava M
    Depress Anxiety; 2006; 23(8):496-501. PubMed ID: 16845662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of triiodothyronine as an augmentation agent in treatment-resistant bipolar II and bipolar disorder NOS.
    Kelly T; Lieberman DZ
    J Affect Disord; 2009 Aug; 116(3):222-6. PubMed ID: 19215985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine and bupropion treatment of bipolar disorder, type II, associated with GAD.
    Novac A
    J Clin Psychiatry; 1992 Feb; 53(2):67. PubMed ID: 1541607
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of bipolar depression with twice-weekly fluoxetine: management of antidepressant-induced mania.
    Megna JL; Devitt PJ
    Ann Pharmacother; 2001 Jan; 35(1):45-7. PubMed ID: 11197585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does olanzapine-fluoxetine combination increase the risk of mania in poorly compliant bipolar depressed patients?
    Reeves RR; Ladner ME
    South Med J; 2005 Nov; 98(11):1152-3. PubMed ID: 16351041
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.